pioglitazone has been researched along with Nephrosis in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Nephrosis: Pathological processes of the KIDNEY without inflammatory or neoplastic components. Nephrosis may be a primary disorder or secondary complication of other diseases. It is characterized by the NEPHROTIC SYNDROME indicating the presence of PROTEINURIA and HYPOALBUMINEMIA with accompanying EDEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we aim to develop a drug-eluting scaffold with a payload of pioglitazone to simultaneously rein in hyperglycemia and recoup lost renal functions in diabetic mice that underwent islet transplantation." | 3.80 | A synergistic therapeutic scheme for hyperglycemia and nephrotic disorders in diabetes. ( Fu, Z; Han, B; He, Q; Tang, K; Xu, J; Yin, H; Zhang, X, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Q | 1 |
| Zhang, X | 1 |
| Han, B | 1 |
| Xu, J | 1 |
| Tang, K | 1 |
| Fu, Z | 1 |
| Yin, H | 1 |
1 other study available for pioglitazone and Nephrosis
| Article | Year |
|---|---|
A synergistic therapeutic scheme for hyperglycemia and nephrotic disorders in diabetes.
Topics: Animals; Blood Urea Nitrogen; Creatinine; Diabetes Complications; Diabetes Mellitus; Humans; Hypergl | 2014 |